Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elamipretide in stable HFpEF
NCT02814097Phase 2Completed
- Sponsor
- Stealth BioTherapeutics
- Start
- Sep 2016
- Primary completion
- May 2017
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of elamipretide in heart failure with preserved ejection fraction (HFpEF), sponsored by Stealth BioTherapeutics. Started Sep 2016; status: completed.
02
Drugs
elamipretide
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02814097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02814097.